Skip to main content
. 2001 Jan 22;2001(1):CD002060. doi: 10.1002/14651858.CD002060

Costello 1995.

Methods Blinding of randomisation: yes 
 Blinding of intervention: can't tell but probably impossible 
 Complete follow‐up: no 
 Blinding of outcome measurement: can't tell
Participants Premature infants 27‐36 weeks GA. 
 No investigation for haemolysis. 
 Qualifying SBR 125‐300. 
 Birthweight significantly lower in fibreoptic group. 
 Fibreoptic n=20, conventional n=24.
Interventions Fibreoptic: BiliBlanket at 35 microwatts/cm2/nm (set). 
 Conventional: white and blue lamps at 8 microwatts/cm2/nm.
Outcomes Duration of phototherapy (no SBR level specified for cessation of phototherapy therefore not included). 
 Use of exchange transfusion. 
 Use of additional phototherapy.
Notes Data complete (no SBR data available)
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment? Low risk A ‐ Adequate